Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Markets can stay calm even when prices rise, but two hidden forces often lurk beneath the surface. This guide identif...
SpaceX's IPO could be a watershed moment for growth investors, but it carries meaningful risks. This guide breaks dow...
A growing investing approach aims to fund car replacements with a dividend-driven portfolio, potentially ending auto ...
A clear-eyed look at how a potential NY State Comptroller would approach investing public funds. This piece breaks do...
Investors increasingly focus on how broadstone lease (bnl) earnings translate into cash flow and dividends. This guid...
In 2022, the S&P 500 plunged while a healthcare-focused ETF held its ground better than most. This story examines why...
A patient fund boosted its stake by roughly $7 million in a major packaging company even though the stock trailed the...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
AI’s hardware backbone goes beyond chips. This deep dive explains why Vertiv and Eaton are pivotal to the AI boom, fr...
A Paychex executive recently sold a small stake, raising questions about the stock's direction. This article explains...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...